1691
|
|
|
Calcium voltage-gated channel auxiliary subunit gamma 8 |
- |
|
1692
|
|
|
Cactin, spliceosome C complex subunit |
C19orf29, NY-REN-24, fSAPc |
|
1693
|
|
|
CDK2 associated cullin domain 1 |
C10orf46, CAC1 |
|
1694
|
|
|
Calcyclin binding protein |
GIG5, PNAS-107, S100A6BP, SIP |
|
1695
|
|
|
Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
CDG1Z, DEE50, EIEE50, GATD4 |
Hypoplastic anemia, Sickle cell anemia, Beta thalassemia, Carbamoyl phosphate synthetase deficiency, Congenital facial anomaly, Congenital hypoplastic anemia, Aplastic anemia, Coronary artery disease, Developmental and epileptic encephalopathy, Epilepsy, Intellectual developmental disorder, Meniere disease, Spherocytosis |
1696
|
|
|
Cell adhesion molecule 1 |
BL2, IGSF4, IGSF4A, NECL2, Necl-2, RA175, ST17, SYNCAM, TSLC1, sTSLC-1, sgIGSF, synCAM1 |
Amyotrophic lateral sclerosis, Anorexia nervosa, Autism, Breast neoplasms, Obstructive pulmonary disease, Major depressive disorder, Eating disorder, Metabolic syndrome, Mitochondrial disease, Obesity, Orofacial cleft, Osteoarthritis, Parkinson disease, Willis-ekbom disease, Schizophrenia, Scoliosis, Diabetes mellitus type 2View all (2 more) |
1697
|
|
|
Cell adhesion molecule 2 |
IGSF4D, NECL3, Necl-3, SynCAM 2, SynCAM-2, synCAM2 |
Alzheimer disease, Astrocytoma, Atrial fibrillation, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Breast cancer, Cannabis abuse, Bronchitis, Obstructive pulmonary disease, Colorectal cancer, Dementia, Diabetes mellitus type 2, Dyskinesia, Eye disease, Glaucoma, Gout, Insomnia, Irritable bowel syndrome, Major depressive disorder, Metabolic syndrome, Migraine, Neurotic disorder, Obesity, Obstructive sleep apnea syndrome, Open angle glaucoma, Psoriasis, Rolandic epilepsy, Schizophrenia, Squamous cell carcinoma, Substance abuseView all (16 more) |
1698
|
|
|
Cell adhesion molecule 3 |
BIgR, CMT2FF, IGSF4B, NECL1, Necl-1, TSLL1, synCAM3 |
|
1699
|
|
|
Calcium dependent secretion activator |
CADPS1, CAPS, CAPS1, UNC-31 |
|
1700
|
|
|
Calcium dependent secretion activator 2 |
CAPS2 |
Alzheimer disease, Atrial fibrillation, Attention deficit hyperactivity disorder, Autism, Breast cancer, Cardiovascular disease, Cholelithiasis, Coronary artery disease, Metabolic syndrome, Osteoarthritis, Schizophrenia, Substance abuse, Diabetes mellitus type 2 |